Granisetron Hydrochloride Tablet, Film Coated
Product Images NDC 69452-350

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Granisetron Hydrochloride (NDC 69452-350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of granisetron hydrochloride, showing the arrangement of atoms and bonds in the compound including the indole ring and bicyclic system with methyl and hydrochloride components.*

FDA Label Image

Container Label (Granisetron Hydrochl Figure 1)

Granisetron Hydrochloride Tablets, USP 1 mg film-coated oral tablets in a package of 20, labeled by Bionpharma Inc. The label includes dosage details, storage instructions, and regulatory information, with a barcode and GTIN visible.*

FDA Label Image

Blister Carton 2s (Granisetron Hydrochl Figure 2)

Granisetron Hydrochloride Tablets, USP 1 mg oral film-coated tablets packaging label. The label displays drug name, strength, dosage form, quantity of 20 unit dose tablets per bottle, manufacturer Bionpharma Inc., and includes regulatory information such as NDC 69452-350-92, usage indication for institutional use only, and dosage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.